bezlotoxumab
Showing 1 - 5 of 5
Clostridium Difficile Trial in Bronx (Bezlotoxumab)
Terminated
- Clostridium Difficile
- Bezlotoxumab
-
Bronx, New YorkMontefiore Medical Center
Oct 13, 2022
Bezlotoxumab for Management of Clostridioides Difficile
Enrolling by invitation
- Clostridium Difficile Infection
- Clostridium Difficile Infection Recurrence
- Bezlotoxumab
- Standard CDI treatment
-
Maywood, IllinoisLoyola University Medical Center
Nov 1, 2022
IBD, Clostridium Difficile Infection Trial in Boston (Bezlotoxumab, Placebo, Fecal Microbiota Transplantation)
Recruiting
- Inflammatory Bowel Diseases
- Clostridium Difficile Infection
- Bezlotoxumab
- +2 more
-
Boston, MassachusettsBrigham and Women's Hospital
Jan 5, 2023
Clostridium Infections, Clostridioides Difficile, Enterocolitis, Pseudomembranous Trial in Netherlands (Bezlotoxumab, Fecal
Not yet recruiting
- Clostridium Infections
- +2 more
- Bezlotoxumab
- +2 more
-
Amsterdam, Netherlands
- +3 more
Oct 15, 2021
Clostridioides Difficile Infection, Stool Microbiome, Organ Dysfunction Syndrome Trial in Greece (Bezlotoxumab, Normal saline
Recruiting
- Clostridioides Difficile Infection
- +4 more
- Bezlotoxumab
- Normal saline 0.9% or 5% dextrose water
-
Alexandroupoli, Greece
- +15 more
May 11, 2022